Prot #SD-809-C-23: A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose study of SD-809 (Deutetrabenazine) for the Treatment of Moderate to Severe Tardive Dyskinesia

Project: Research project

Project Details

StatusFinished
Effective start/end date5/18/15 → 5/18/18

Funding

  • INNO Clinical Outcomes, LLC (Prot #SD-809-C-23 // Prot #SD-809-C-23)
  • Auspex Pharmaceuticals, Inc. (Prot #SD-809-C-23 // Prot #SD-809-C-23)